Glucocorticoid-induced osteoporosis update : Current Opinion in Rheumatology
Glucocorticoid-induced osteoporosis update : Current Opinion in Rheumatology Log in or …

Glucocorticoid-induced osteoporosis (GIOP) is one of the most common and serious
adverse effects associated with glucocorticoid use. GIOP, the most common secondary form …

Therapeutic use of glucocorticoids can lead to many well-known adverse events [1]. Of all
potential serious side effects, glucocorticoid-induced osteoporosis (GIOP) is one of the most …

Among the adverse events of glucocorticoid treatment are bone loss and fractures. Despite
available, effective preventive measures, many patients receiving or initiating glucocorticoid …

Glucocorticoids are the most common cause of drug-related osteoporosis. We reviewed
current evidence on risk factors for glucocorticoid-induced osteoporosis (GIOP) and …

Glucocorticoids are effective immunomodulatory drugs used for many inflammatory
disorders as well as in transplant recipients. However, both iatrogenic and endogenous …

Glucocorticoids remain widely used for many medical conditions, and fractures are the most
serious common adverse event related to long-term glucocorticoid use. Glucocorticoid …

Introduction Glucocorticoid (GC) induced osteoporosis (GIOP) is the most common form of
secondary osteoporosis. It develops in a dose and time dependent manner, due to a rapid …

An update on glucocorticoid-induced osteoporosis : Current Opinion in Rheumatology An
update on glucocorticoid-induced osteoporosis : Current Opinion in Rheumatology Log in or …

This review summarizes the available evidence-based data that form the basis for
therapeutic intervention and covers the current status of glucocorticoid-induced osteoporosis …